Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06018116
Title A Canadian Phase II Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer (CANUCK-01)
Acronym CANUCK-01
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors CHU de Quebec-Universite Laval
Indications
Therapies
Age Groups: senior | adult
Covered Countries CAN


No variant requirements are available.